Revelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral Infections
– Phase 2b study will investigate the efficacy of REVTx-99 on viral load and patient-reported…
Keeper Security Delivers Structured Governance for Humans and AI Agents with New PAM Approval Workflows in KeeperPAM
Integrated Quantum Launches $10K Kaggle Hackathon to ‘Pierce the VEIL’
CleanStart Launches Cleansight To Uncover Hidden Container Risk And Map Vulnerabilities To Trusted Replacement Images